These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17688287)

  • 1. Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis.
    Balch C; Nephew KP; Huang TH; Bapat SA
    Bioessays; 2007 Sep; 29(9):842-5. PubMed ID: 17688287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetic analyses of brain tumor stem cells].
    Natsume A; Kondo Y; Wakabayashi T
    Brain Nerve; 2009 Jul; 61(7):791-8. PubMed ID: 19618856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RE1 Silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells.
    Greenway DJ; Street M; Jeffries A; Buckley NJ
    Stem Cells; 2007 Feb; 25(2):354-63. PubMed ID: 17082226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional and epigenetic regulations of embryonic stem cells.
    Ng JH; Heng JC; Loh YH; Ng HH
    Mutat Res; 2008 Dec; 647(1-2):52-8. PubMed ID: 18778721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
    Ohm JE; McGarvey KM; Yu X; Cheng L; Schuebel KE; Cope L; Mohammad HP; Chen W; Daniel VC; Yu W; Berman DM; Jenuwein T; Pruitt K; Sharkis SJ; Watkins DN; Herman JG; Baylin SB
    Nat Genet; 2007 Feb; 39(2):237-42. PubMed ID: 17211412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stemness is only a state of the cell.
    Kagalwala MN; Singh SK; Majumder S
    Cold Spring Harb Symp Quant Biol; 2008; 73():227-34. PubMed ID: 19150961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
    Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
    Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
    Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
    Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of Hox gene activation: the waltz of methyls.
    Soshnikova N; Duboule D
    Bioessays; 2008 Mar; 30(3):199-202. PubMed ID: 18293357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
    Baylin SB; Ohm JE
    Nat Rev Cancer; 2006 Feb; 6(2):107-16. PubMed ID: 16491070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression in ES cells.
    Cheong CY; Lufkin T
    J Cell Biochem; 2010 May; 110(2):288-93. PubMed ID: 20336663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.
    Ron-Bigger S; Bar-Nur O; Isaac S; Bocker M; Lyko F; Eden A
    Stem Cells; 2010 Aug; 28(8):1349-54. PubMed ID: 20572015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
    Atkinson S; Armstrong L
    Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell regulation by polycomb repressors: postponing commitment.
    Pietersen AM; van Lohuizen M
    Curr Opin Cell Biol; 2008 Apr; 20(2):201-7. PubMed ID: 18291635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.